Eligibility for Thrombolysis for Pediatric Acute Ischemic Stroke
Stroke · 2026-10 · 57 (10) · 3000-3009
DOI: 10.1161/strokeaha.125.054223 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Stroke, 2026-10. Verfasst von Romain C Briest und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Sydney Children's Hospital, Randwick, New South Wales, Australia (R.C.B., A.M.B., M.C., D.L.C., M.A.F., A.J., T.K., J.L., S.…. Hauptthemen laut MEDLINE: Ischemic Stroke, Thrombolytic Therapy, Tissue Plasminogen Activator, Fibrinolytic Agents. Die Arbeit nennt 31 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: Thrombolysis is infrequently delivered to children with acute ischemic strokes (AIS). We explored potential eligibility for treatment with tPA (tissue-type plasminogen activator) for pediatric AIS. METHODS: This retrospective, multicenter, observational, cohort study reviewed children aged 29 days to 17 years with symptomatic AIS identified via Children’s Hospital Westmead, John Hunter Children’s Hospital, and Sydney Children’s Hospital between January 1, 2010, and December 31, 2019. Medical records were examined to evaluate eligibility for treatment with tPA based on established multinational and the 2026 American Heart Association guidelines, reasons for exclusion beyond delay to diagnosis, and long-term outcomes as pediatric modified Rankin Scale scores. We also explored additional exclusions and outcomes among children with small-vessel AIS and AIS in the context of brain tumors, who are currently excluded from tPA. RESULTS: A total of 135 patients with 139 symptomatic AIS were identified—median age, 6 years; 36% female patients; 73% presented via emergency departments; mean follow-up, 43 months; 12% deaths. Irrespective of delay to diagnosis, only 26 of 139 (19%) AIS were potentially eligible for treatment with tPA. Among patients potentially eligible for tPA, acute neuroimaging revealed large-vessel occlusions, unilateral focal cerebral arteriopathy, or extracranial dissections. Thirteen of 26 (50%) had nondisabled outcomes without tPA treatment. One hundred thirteen of 139 (81%) AIS were ineligible for treatment with tPA, irrespective of delay to diagnosis. All deaths occurred among patients excluded from tPA, predominantly related to underlying disorders. Fifty-four small-vessel AIS accounted for 39% of AIS. Eighteen (33%) had no additional ineligibilities to thrombolysis, among whom 10 had nondisabled outcomes without tPA. CONCLUSIONS: Based on current recommendations, 19% of symptomatic childhood AIS were potentially eligible for treatment with tPA, irrespective of delay to diagnosis. Selected patients with small-vessel AIS may offer an opportunity to extend the role of tPA. These observations may be relevant for optimizing pediatric stroke management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Sydney Children's Hospital, Randwick, New South Wales, Australia (R.C.B., A.M.B., M.C., D.L.C., M.A.F., A.J., T.K., J.L., S.C.P., H.S., H.L.T., P.I.A.).
- Department of Medical Imaging, Children's Hospital at Westmead, New South Wales, Australia (K.D.B.).
- Department of Neurology, John Hunter Children's Hospital, Newcastle, New South Wales, Australia (C.M., F.M., R.L.S., G.M.S.).
- Department of Neurointervention, Prince of Wales Hospital, Randwick, New South Wales, Australia (A.C., N.W.M., A.M., J. Wenderoth, J. Whitley).
- T.Y. Nelson Department of Neurology and Neurosurgery, Children's Hospital at Westmead, Westmead and University of Sydney, New South Wales, Australia (J.A., S.A.-H., R.C.D., D.G., S.G., M.P.M., C.T., R.I.W.).
- Discipline of Paediatrics and Child Health, Randwick Clinical Campus, School of Clinical Medicine, Faculty of Medicine and Health, UNSW, Sydney, Australia (A.B., M.C., D.L.C., M.F., A.J., T.K., H.S., H.L.T.).
ORCID-Profile: Romain C Briest, Kartik D Bhatia, Christina Miteff, Andrew Cheung, Michael Cardamone, Denise L Chan, Michelle A Farrar, Deepak Gill, Sachin Gupta, John Lawson, Nathan W Manning, Alexander McQuinn, Manoj P Menezes, Ferdinand Miteff, Sekhar C Pillai, Gopinath Musuwadi Subramanian, Richard I Webster, Justin Whitley, P Ian Andrews
Zitieren
APA
Briest, R. C., Bhatia, K. D., Miteff, C., Cheung, A., Antony, J., Ardern-Holmes, S., Bye, A. M., Cardamone, M., Chan, D. L., Dale, R. C., Farrar, M. A., Gill, D., Gupta, S., Johnson, A., Kandula, T., Lawson, J., Manning, N. W., McQuinn, A., Menezes, M. P., …, & Andrews, P. I. (2026). Eligibility for Thrombolysis for Pediatric Acute Ischemic Stroke. Stroke, 57(10), 3000-3009. https://doi.org/10.1161/strokeaha.125.054223
Vancouver
Briest RC, Bhatia KD, Miteff C, Cheung A, Antony J, Ardern-Holmes S, et al. Eligibility for Thrombolysis for Pediatric Acute Ischemic Stroke. Stroke. 2026;57(10):3000-3009. doi:10.1161/strokeaha.125.054223
BibTeX
@article{Briest2026,
author = {Briest, Romain C and Bhatia, Kartik D and Miteff, Christina and Cheung, Andrew and Antony, Jayne and Ardern-Holmes, Simone and Bye, Ann M and Cardamone, Michael and Chan, Denise L and Dale, Russell C and Farrar, Michelle A and Gill, Deepak and Gupta, Sachin and Johnson, Alexandra and Kandula, Tejaswi and Lawson, John and Manning, Nathan W and McQuinn, Alexander and Menezes, Manoj P and Miteff, Ferdinand and Pillai, Sekhar C and Sampaio, Hugo and Smith, Robert L and Subramanian, Gopinath Musuwadi and Teoh, Hooi Ling and Troedson, Christopher and Webster, Richard I and Wenderoth, Jason and Whitley, Justin and Andrews, P Ian},
title = {Eligibility for Thrombolysis for Pediatric Acute Ischemic Stroke},
journal = {Stroke},
year = {2026},
volume = {57},
number = {10},
pages = {3000--3009},
doi = {10.1161/strokeaha.125.054223}
}
EUVIMED